Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

E.D. Tex.

Sanofi-Aventis Deutschland GmbH v. Genentech, Inc. et al, No. 9:08-cv-00203 (E.D. Tex. Mar. 19, 2009)

Denied
Venue / Transfer
Court
U.S. District Court for the Eastern District of Texas, Lufkin Division
Case No.
No. 9:08-cv-00203, Dkt. No. 43
Decided
March 19, 2009
Judge
Ron Clark, J.
Document
Order
Docket Entry
VACATED PER COURT ORDER 61---ORDER denying 31 Defendants Genetech, Inc. and Biogen Idec, Inc.s Motion to Transfer Venue
Length
19 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

DENYING DEFENDANTS’ MOTION TO CHANGE VENUE Plaintiff Sanofi-Aventis Deutschland GmbH (“Sanofi”) filed suit against Defendants Genentech, Inc. and Biogen Idec Inc., claiming that nine of Genentech’s biotherapeutics infringe United States Patent Nos. 5,849,522 and 6,218,140. Both of the patents are directed toward nucleic acid enhancers for cellular expression systems that can be used to produce drugs or antibodies for human therapy.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error